No Benefit to Third Parties. The representations, warranties, covenants and agreements set forth in this Agreement are for the sole benefit of the parties hereto and their successors and permitted assigns, and they will not be construed as conferring any rights on any other persons. * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
Appears in 7 contracts
Samples: Development and Manufacturing Services Agreement (Rhythm Pharmaceuticals, Inc.), Development and Manufacturing Services Agreement (Rhythm Pharmaceuticals, Inc.), Development and Manufacturing Services Agreement (Rhythm Pharmaceuticals, Inc.)
No Benefit to Third Parties. The representations, warranties, covenants and agreements set forth in this Agreement are for the sole benefit of the parties hereto Parties and their successors and permitted assigns, and they will shall not be construed as conferring any rights on any other personsPersons. * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 PROMULGATED UNDER THE SECURITIES ACT OF of the Securities Act of 1933, AS AMENDEDas amended.
Appears in 2 contracts
Samples: License Agreement (Zai Lab LTD), License Agreement (Zai Lab LTD)
No Benefit to Third Parties. The representations, warranties, covenants and agreements set forth in this Agreement are for the sole benefit of the parties hereto Parties and their successors and permitted assigns, and they will shall not be construed as conferring any rights on any other personsPersons. *** CONFIDENTIAL TREATMENT REQUESTEDThis portion has been redacted pursuant to a confidential treatment request under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDEDA complete copy of this document has been filed separately with the Securities and Exchange Commission.
Appears in 1 contract
Samples: Development, Marketing and Supply Agreement (Axovant Sciences Ltd.)
No Benefit to Third Parties. The representations, warranties, covenants warranties and agreements set forth in this Agreement are for the sole benefit of the parties hereto Parties and their successors and permitted assigns, and they will shall not be construed as conferring any rights on any other personsparties. * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933[*] = Certain confidential information contained in this document, AS AMENDEDmarked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 1 contract
Samples: Master Clinical Trial Collaboration Agreement (Compugen LTD)
No Benefit to Third Parties. The representations, warranties, covenants and agreements set forth in this Agreement are for the sole benefit of the parties hereto and their successors and permitted assigns, and they will not be construed as conferring any rights on any other persons. [Signature page follows] * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
Appears in 1 contract
